Nucala 100 mg powder for solution for injection
- Licence status
- Active substances
- Mepolizumab
- Dosage Form
- Powder for solution for injection
- Licence number
- EU/1/15/1043/001-002
- Licence holder
- GlaxoSmithKline Trading Services Limited
Product documents
Licence information
- ATC code
- R03DX Other systemic drugs for obstructive airway diseases
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 02/12/2015